Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator ...
As the independent wealth management industry in Asia continues to develop, firms are increasingly being shaped not only by ...
At the Hubbis Independent Wealth Management Forum - Hong Kong 2026, industry leaders examined whether independent wealth ...
This column explores a much-needed book that examines DEI in accounting from the European perspective. All too often, DEI in ...